Corporate News – Dook (301025.SZ)

  • Trading Performance (24 h ending 10:28 PM Central Europe, Friday 23 Oct 2026)

  • Price change: 0 %

  • Current trading price: CNY 9.82

  • Current market capitalisation: CNY 4.2 bn

  • Total shares outstanding: 391.6 mn

  • Volume traded in the last 24 h: CNY 256.2 mn

  • 24‑hour trading activity: -2.19 % relative to the end of last month

  • Technical Indicators

  • 200‑day simple moving average: CNY 9.17

  • 52‑week high: CNY 16.58 (02 Nov 2026)

  • 52‑week low: CNY 7.37 (27 Jul 2026)

  • Recent Earnings Update (22 Oct 2026)

  • Operating income increased modestly year‑to‑year.

  • Net profit more than doubled, primarily due to gains from financial services and government subsidies.

  • Management announced a strategic shift toward a dual‑focus model, combining cross‑border digital trade with AI‑enabled computing infrastructure.

  • Server‑trade operations, which commenced large‑scale delivery in August, have begun contributing to top‑line growth.

  • Analysts view the diversification as aligned with industry trends in AI and digital commerce, potentially supporting further profitability expansion as new business lines mature.

  • Peer Performance (24 h)

TickerCurrent PriceMarket Cap24‑h Movement
300087.SZ – Winall Hi‑tech SeedCNY 5.24CNY 5 bn0 %
603170.SS – Shanghai Bolex Food TechnCNY 12.69CNY 5 bn0 %
9626.HK – BilibiliHKD 106.2HKD 5.9 bn-3.81 %
002796.SZ – Suzhou Shijia Science & TeCNH 20.77CNH 5.4 bn0 %
002728.SZ – Teyi PharmaceuticalCNY 8.99CNY 5 bn0 %
  • Additional Metrics
  • Bilibili: Current P/E ratio 27.17.
  • Teyi Pharmaceutical: Current P/E ratio 64.34.

This summary provides a concise, factual overview of Dook’s recent trading activity, technical status, earnings development, and relative performance against selected peers.